Maxim Group
http://www.maximgrp.com/Maxim Group is a financial services firm that provides investment banking, asset management, research, and sales & trading to a diverse range of corporate clients, institutional investors and high net worth individuals.
The firm’s research division uses fundamental research and a “bottom up” approach to making investment recommendations. Maxim’s research analysts focus on under-covered, small- to mid-cap names in a variety of sectors including healthcare, technology, retail and others.
View Older Stories View More Recent Stories
-
Rock Creek Pharma (RCPI) to Raise $3.7M in Direct Offering
-
Rock Creek Pharmaceuticals Announces $3.7 Million Registered Direct Offering
-
Maxim Group Starts Astec Industries (ASTE) at Buy
-
BioCardia, Inc. Files Registration Statement for Proposed Initial Public Offering
-
Buy bluebird bio (BLUE) on Weakness Tied to Avalanche (AAVL) Blow-Up, Maxim Group Says
-
Blue Sphere Corp Announces Engagement of Maxim Group LLC to Provide Strategic Advisory Services
-
Maxim Group Downgrades Profire Energy (PFIE) to Hold
-
Wheeler Real Estate Investment Trust, Inc. Commences Exchange Offer for Series A Preferred Stock and Series B Preferred Stock
-
Streetinsider.com's Hot Lunchtime Reads 6/15: (CI) (AAPL) (AIG) (TGT) (TKMR) (MU)
-
Maxim Group Downgrades Tekmira Pharma (TKMR) to Hold
-
Maxim Group LLC Expands Capital Markets Platform With the Addition of a Regional and Community Banking Group
-
bluebird bio (BLUE) Looks to Have Cured First Sickle Cell Patient, Maxim Group Notes
-
Impact Investor Conference Expands to 3 Tracks
-
Impact Investor Conference Expands to 3 Tracks
-
Oncosec Medical (ONCS) Reports Wider Nine-Month Loss of $1.19/Share for 2015; Closes Direct Offering
-
OncoSec Medical Closes $13.6 Million Registered Direct Offering
-
Breathe, eCig Corp. Officially Launches Its Product Line in New York City and Eastern Tennessee
-
Medivation's (MDVN) Xtandi Has Great Potential in Breast Cancer, Maxim Group Says; PT to $168
-
Oxford Lane Capital Corp. Prices Public Offering of Common Stock
-
Oxford Lane (OXLC) Announces 2.25M Common Stock Offering
-
Oxford Lane Capital Corp. Commences Public Offering of Common Stock
-
Oncosec Medical Incorporated (ONCS) Enters 2.47M Common Direct Offering at $5.50/Share
-
OncoSec Medical Announces $13.6 Million Registered Direct Offering
-
Nova LifeStyle, Inc. Announces Closing of $4 Million Registered Direct Offering
-
StemCells, Inc. Announces Closing of Over-Allotment Option
-
Hemisphere Media Group Announces Closing of Underwriters’ Option to Purchase Additional Shares
-
NeuroMetrix Closes $14.7 Million Public Offering
-
Claims Administrator Angeion Group Announces Proposed Settlement In China-Biotics Class Action
-
Nova LifeStyle, Inc. Announces $4 Million Registered Direct Offering
-
Nova Lifestyle (NVFY) Enters 2.97M Common Registered Direct Offering
-
Celsion (CLSN) to Offer $8M in Common Stock Through Registered Direct Offering
-
Celsion Corporation Announces $8 Million At-The-Market Registered Direct Offering
-
Maxim Group Starts Sterling Construction (STRL) at Buy
-
Notable Analyst Rating Changes 5/27: (AMED) (FTR) (CSC) Upgraded; (YHOO) (TMUS) (GEF) Downgraded
-
Pre-Open Stock Movers 05/27: (EOX) (OPXA) (TIF) Higher; (KORS) (WDAY) (CHS) Lower (more...)
-
Time to Focus on Galena Biopharma (GALE) Ahead of ASCO, Maxim Group Says
-
NeuroMetrix Prices Public Offering of $14.7 Million of Convertible Preferred Stock and Warrants
-
Maxim Group Starts Opexa Therapeutics (OPXA) at Buy, $5 PT
-
NovaBay Pharma (NBY) Enters $6.86M ATM Private Placement of Stock
-
NovaBay Announces $6.86 Million “At Market” Private Placement
-
AmbiCom Holdings, Inc. Announces Engagement of Investment Banking Firm Maxim Group LLC to Provide Strategic Advisory Services
-
IsoRay (ISR) Results 'Exceptional', Maxim Group Says; Reiterates Buy Rating, $5 PT
-
Maxim Still Bullish on IsoRay (ISR) Following Q1 Results; More Physicians Adopting Cesium-131
-
Concept Capital Markets adds trading and client support personnel
-
Gladstone Investment Corporation Announces Closing of Offering of 1,610,000 Shares of Its 6.50% Series C Cumulative Term Preferred Stock for Gross Proceeds of Approximately $40.3 Million
-
Gladstone Land (LAND) Prices Larger 1.25M Common Offering at $11.40/Share
-
Gladstone Land Corporation Prices Common Stock Offering
-
Gladstone Land Corporation Prices Common Stock Offering
-
Maxim Group Maintains Hold Leading up to Urban Outfitters (URBN) Q1 Release
-
Pre-Open Stock Movers 05/13: (WPZ) (HDP) (PLL) Higher; (OREX) (VSLR) (DD) Lower (more...)

